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Background: Reactivation of Wnt-signalling in cardiac remodelling has been shown in experimental models. Interruption of this signalling 
attenuates the hypertrophic response to pressure overload. We hypothesized that serum levels of inhibitors of the Wnt-signalling pathway could 
provide prognostic information in patients with chronic heart failure (HF).
Methods: We included 182 patients with chronic HF in NYHA class II-IV. During a mean follow-up of 37 (±17) months, 53 patients died or 
underwent heart transplantation (HTx). Soluble inhibitors of the Wnt pathway, secreted frizzled-related protein 3 (sFRP3), Wnt inhibitory factor 1 
(WIF-1) and dickkopf-1 (DKK-1), were measured by ELISA technique.
Results: HF patients had elevated levels of sFRP3 and WIF-1, and decreased DKK-1 compared to controls (p-values <0.01). Both WIF-1 and sFRP3 
were positively correlated to left ventricular end diastolic volume (r=0.269 and r=0.272, p< 0.001 for both) and systolic volume (r=0.212 and 
r=0.191, p<0.02 for both). WIF-1-levels were inversely correlated with ejection fraction (r=-0.250, p=0.002). ). Increased sFRP3 (above median 180 
pg/mL) was strongly associated with increased mortality/HTx [HR 2.20 (1.23-3.94), p=0.007], even after multivariate analysis (p=0.022).
Conclusions: Serum levels of sFRP3 and WIF-1 are elevated in HF patients and are related to cardiac dimension and systolic function. High levels 
of sFRP3 predict a poor outcome.
